AU2007287006B2 - System for abating neural stimulation side effects - Google Patents
System for abating neural stimulation side effects Download PDFInfo
- Publication number
- AU2007287006B2 AU2007287006B2 AU2007287006A AU2007287006A AU2007287006B2 AU 2007287006 B2 AU2007287006 B2 AU 2007287006B2 AU 2007287006 A AU2007287006 A AU 2007287006A AU 2007287006 A AU2007287006 A AU 2007287006A AU 2007287006 B2 AU2007287006 B2 AU 2007287006B2
- Authority
- AU
- Australia
- Prior art keywords
- neural stimulation
- side effect
- stimulation therapy
- therapy
- neural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000638 stimulation Effects 0.000 title claims abstract description 309
- 230000001537 neural effect Effects 0.000 title claims abstract description 276
- 230000000694 effects Effects 0.000 title claims abstract description 151
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 196
- 206010011224 Cough Diseases 0.000 claims abstract description 48
- 230000002051 biphasic effect Effects 0.000 claims abstract description 48
- 238000000034 method Methods 0.000 claims abstract description 45
- 230000000747 cardiac effect Effects 0.000 claims description 46
- 230000004044 response Effects 0.000 claims description 15
- 230000000241 respiratory effect Effects 0.000 claims description 8
- 230000001225 therapeutic effect Effects 0.000 claims description 8
- 238000013479 data entry Methods 0.000 claims description 3
- 230000001360 synchronised effect Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 22
- 210000005036 nerve Anatomy 0.000 description 38
- 210000002216 heart Anatomy 0.000 description 32
- 210000001186 vagus nerve Anatomy 0.000 description 22
- 206010019280 Heart failures Diseases 0.000 description 21
- 206010020772 Hypertension Diseases 0.000 description 20
- 230000002889 sympathetic effect Effects 0.000 description 20
- 230000001965 increasing effect Effects 0.000 description 17
- 230000002861 ventricular Effects 0.000 description 15
- 208000001871 Tachycardia Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 208000010125 myocardial infarction Diseases 0.000 description 14
- 108091008698 baroreceptors Proteins 0.000 description 12
- 230000036772 blood pressure Effects 0.000 description 12
- 238000007726 management method Methods 0.000 description 12
- 210000001774 pressoreceptor Anatomy 0.000 description 12
- 238000004891 communication Methods 0.000 description 11
- 238000001514 detection method Methods 0.000 description 11
- 230000002107 myocardial effect Effects 0.000 description 11
- 210000004165 myocardium Anatomy 0.000 description 11
- 208000033774 Ventricular Remodeling Diseases 0.000 description 10
- 230000035581 baroreflex Effects 0.000 description 10
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 10
- 230000003750 conditioning effect Effects 0.000 description 10
- 230000008602 contraction Effects 0.000 description 10
- 230000035479 physiological effects, processes and functions Effects 0.000 description 10
- 230000004936 stimulating effect Effects 0.000 description 10
- 210000002820 sympathetic nervous system Anatomy 0.000 description 10
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 9
- 238000007634 remodeling Methods 0.000 description 9
- 230000001746 atrial effect Effects 0.000 description 8
- 230000008035 nerve activity Effects 0.000 description 8
- 230000033764 rhythmic process Effects 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 7
- 230000001734 parasympathetic effect Effects 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 230000036316 preload Effects 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000035939 shock Effects 0.000 description 7
- 230000036471 bradycardia Effects 0.000 description 6
- 208000006218 bradycardia Diseases 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- 238000004448 titration Methods 0.000 description 6
- 238000002604 ultrasonography Methods 0.000 description 6
- 206010020880 Hypertrophy Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000002837 heart atrium Anatomy 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000011514 reflex Effects 0.000 description 5
- 230000006794 tachycardia Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000001515 vagal effect Effects 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000002567 autonomic effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 4
- 210000004731 jugular vein Anatomy 0.000 description 4
- 208000031225 myocardial ischemia Diseases 0.000 description 4
- 230000007383 nerve stimulation Effects 0.000 description 4
- 210000000653 nervous system Anatomy 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000001960 triggered effect Effects 0.000 description 4
- 208000030814 Eating disease Diseases 0.000 description 3
- 208000019454 Feeding and Eating disease Diseases 0.000 description 3
- 208000019695 Migraine disease Diseases 0.000 description 3
- 208000016285 Movement disease Diseases 0.000 description 3
- 206010049447 Tachyarrhythmia Diseases 0.000 description 3
- 230000003206 anti-remodeling effect Effects 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 230000004872 arterial blood pressure Effects 0.000 description 3
- 238000013528 artificial neural network Methods 0.000 description 3
- 238000013194 cardioversion Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 235000014632 disordered eating Nutrition 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 208000018672 Dilatation Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000009612 Laryngismus Diseases 0.000 description 2
- 206010023891 Laryngospasm Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 210000002376 aorta thoracic Anatomy 0.000 description 2
- 210000003192 autonomic ganglia Anatomy 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000005242 cardiac chamber Anatomy 0.000 description 2
- 210000001326 carotid sinus Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 208000035850 clinical syndrome Diseases 0.000 description 2
- 230000001447 compensatory effect Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 230000003843 mucus production Effects 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 230000008701 parasympathetic activation Effects 0.000 description 2
- 230000036513 peripheral conductance Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 238000000718 qrs complex Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000001044 sensory neuron Anatomy 0.000 description 2
- 230000000392 somatic effect Effects 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 206010047302 ventricular tachycardia Diseases 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010003130 Arrhythmia supraventricular Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 206010052337 Diastolic dysfunction Diseases 0.000 description 1
- 241001632160 Dismorphiinae Species 0.000 description 1
- 208000002251 Dissecting Aneurysm Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 206010024119 Left ventricular failure Diseases 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 208000014139 Retinal vascular disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000287181 Sturnus vulgaris Species 0.000 description 1
- 206010071436 Systolic dysfunction Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 208000009982 Ventricular Dysfunction Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 229940030602 cardiac therapy drug Drugs 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000002644 neurohormonal effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 210000004345 peroneal nerve Anatomy 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009158 reflex pathway Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000002633 shock therapy Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 230000009943 skeletal muscle blood flow Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000001321 subclavian vein Anatomy 0.000 description 1
- 230000008700 sympathetic activation Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000006815 ventricular dysfunction Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36132—Control systems using patient feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
- A61B5/4041—Evaluating nerves condition
- A61B5/4047—Evaluating nerves condition afferent nerves, i.e. nerves that relay impulses to the central nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
- A61B5/4035—Evaluating the autonomic nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3601—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Electrotherapy Devices (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012200979A AU2012200979B2 (en) | 2006-08-25 | 2012-02-20 | System for abating neural stimulation side effects |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/467,264 US8103341B2 (en) | 2006-08-25 | 2006-08-25 | System for abating neural stimulation side effects |
| US11/467,264 | 2006-08-25 | ||
| PCT/US2007/072444 WO2008024557A1 (en) | 2006-08-25 | 2007-06-29 | System for abating neural stimulation side effects |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012200979A Division AU2012200979B2 (en) | 2006-08-25 | 2012-02-20 | System for abating neural stimulation side effects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2007287006A1 AU2007287006A1 (en) | 2008-02-28 |
| AU2007287006B2 true AU2007287006B2 (en) | 2011-11-24 |
Family
ID=38707284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007287006A Ceased AU2007287006B2 (en) | 2006-08-25 | 2007-06-29 | System for abating neural stimulation side effects |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US8103341B2 (https=) |
| EP (2) | EP2902076A1 (https=) |
| JP (1) | JP2010501269A (https=) |
| CN (2) | CN101505827B (https=) |
| AU (1) | AU2007287006B2 (https=) |
| WO (1) | WO2008024557A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8897881B2 (en) | 2006-08-25 | 2014-11-25 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
Families Citing this family (174)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003530184A (ja) * | 2000-04-17 | 2003-10-14 | ビボメトリックス，インコーポレイテッド | 生理学的徴候を着装携行式にモニタするモニタ装置、システムおよび記録媒体 |
| US20080082018A1 (en) * | 2003-04-10 | 2008-04-03 | Sackner Marvin A | Systems and methods for respiratory event detection |
| US7727161B2 (en) * | 2003-04-10 | 2010-06-01 | Vivometrics, Inc. | Systems and methods for monitoring cough |
| US20040226556A1 (en) * | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
| US9492084B2 (en) * | 2004-06-18 | 2016-11-15 | Adidas Ag | Systems and methods for monitoring subjects in potential physiological distress |
| US9504410B2 (en) * | 2005-09-21 | 2016-11-29 | Adidas Ag | Band-like garment for physiological monitoring |
| AU2006236306A1 (en) * | 2005-04-20 | 2006-10-26 | Vivometrics, Inc. | Systems and methods for non-invasive physiological monitoring of non-human animals |
| US7878979B2 (en) | 2005-05-20 | 2011-02-01 | Adidas Ag | Methods and systems for determining dynamic hyperinflation |
| JP5826450B2 (ja) | 2005-07-22 | 2015-12-02 | ザ ファウンドリー， エルエルシー | 治療薬の送達のためのシステムおよび方法 |
| US12433837B2 (en) | 2005-07-22 | 2025-10-07 | The Foundry, Llc | Systems and methods for delivery of a therapeutic agent |
| US8033996B2 (en) | 2005-07-26 | 2011-10-11 | Adidas Ag | Computer interfaces including physiologically guided avatars |
| US8762733B2 (en) * | 2006-01-30 | 2014-06-24 | Adidas Ag | System and method for identity confirmation using physiologic biometrics to determine a physiologic fingerprint |
| US20070270671A1 (en) * | 2006-04-10 | 2007-11-22 | Vivometrics, Inc. | Physiological signal processing devices and associated processing methods |
| US8475387B2 (en) * | 2006-06-20 | 2013-07-02 | Adidas Ag | Automatic and ambulatory monitoring of congestive heart failure patients |
| US9352161B2 (en) | 2006-10-26 | 2016-05-31 | Boston Scientific Neuromodulation Corporation | Method of maintaining intensity output while adjusting pulse width or amplitude |
| US9833184B2 (en) * | 2006-10-27 | 2017-12-05 | Adidas Ag | Identification of emotional states using physiological responses |
| US20080167696A1 (en) * | 2006-12-28 | 2008-07-10 | Cvrx, Inc. | Stimulus waveforms for baroreflex activation |
| ES2430613T3 (es) * | 2007-01-29 | 2013-11-21 | Simon Fraser University | Aparato de neuroestimulación transvascular |
| EP2126828A4 (en) * | 2007-02-16 | 2012-01-25 | Bodymedia Inc | SYSTEMS AND METHODS FOR UNDERSTANDING AND APPLYING THE PHYSIOLOGICAL AND CONTEXTUAL LIFE PATTERNS OF ONE OR MORE INDIVIDUALS |
| US8224453B2 (en) | 2007-03-15 | 2012-07-17 | Advanced Neuromodulation Systems, Inc. | Spinal cord stimulation to treat pain |
| US8406877B2 (en) * | 2007-03-19 | 2013-03-26 | Cardiac Pacemakers, Inc. | Selective nerve stimulation with optionally closed-loop capabilities |
| US20080262557A1 (en) * | 2007-04-19 | 2008-10-23 | Brown Stephen J | Obesity management system |
| US8781595B2 (en) | 2007-04-30 | 2014-07-15 | Medtronic, Inc. | Chopper mixer telemetry circuit |
| US11376435B2 (en) * | 2007-07-20 | 2022-07-05 | Boston Scientific Neuromodulation Corporation | System and method for shaped phased current delivery |
| CA2694498C (en) | 2007-07-20 | 2014-12-02 | Boston Scientific Neuromodulation Corporation | Use of stimulation pulse shape to control neural recruitment order and clinical effect |
| US20130304152A1 (en) * | 2012-05-14 | 2013-11-14 | Boston Scientific Neuromodulation Corporation | System and method for shaped phased current delivery |
| US8380314B2 (en) | 2007-09-26 | 2013-02-19 | Medtronic, Inc. | Patient directed therapy control |
| US7848816B1 (en) | 2007-12-27 | 2010-12-07 | Pacesetter, Inc. | Acquiring nerve activity from carotid body and/or sinus |
| US7949398B1 (en) * | 2007-12-27 | 2011-05-24 | Pacesetter, Inc. | Acquiring nerve activity from carotid body and/or sinus |
| WO2009094050A1 (en) | 2008-01-25 | 2009-07-30 | Medtronic, Inc. | Sleep stage detection |
| US11305121B2 (en) * | 2013-03-15 | 2022-04-19 | Flint Hills Scientific, Llc. | Programmable autotitrating of electrical parameters of implantable medical device |
| US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
| US8805518B2 (en) * | 2008-05-09 | 2014-08-12 | Medtronic, Inc. | Peripheral nerve field stimulation control |
| US8088127B2 (en) | 2008-05-09 | 2012-01-03 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
| AU2012261486B2 (en) * | 2008-07-08 | 2014-02-27 | Cardiac Pacemakers, Inc. | Systems for delivering vagal nerve stimulation |
| EP2334372A1 (en) | 2008-07-08 | 2011-06-22 | Cardiac Pacemakers, Inc. | Systems for delivering vagal nerve stimulation |
| US8463376B2 (en) | 2008-08-12 | 2013-06-11 | Guy P. Curtis | System and method for transvascular activation of cardiac nerves with automatic restart |
| US20100042185A1 (en) * | 2008-08-12 | 2010-02-18 | Curtis Guy P | System and method for transvascular activation of cardiac nerves to improve heart function |
| US8457747B2 (en) | 2008-10-20 | 2013-06-04 | Cyberonics, Inc. | Neurostimulation with signal duration determined by a cardiac cycle |
| US8611996B2 (en) * | 2008-10-31 | 2013-12-17 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8260412B2 (en) * | 2008-10-31 | 2012-09-04 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8386053B2 (en) * | 2008-10-31 | 2013-02-26 | Medtronic, Inc. | Subclavian ansae stimulation |
| US9775987B2 (en) * | 2008-10-31 | 2017-10-03 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8452394B2 (en) * | 2008-10-31 | 2013-05-28 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8688210B2 (en) * | 2008-10-31 | 2014-04-01 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8249708B2 (en) * | 2008-10-31 | 2012-08-21 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US9597505B2 (en) * | 2008-10-31 | 2017-03-21 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8774918B2 (en) * | 2008-10-31 | 2014-07-08 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8532779B2 (en) * | 2008-10-31 | 2013-09-10 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8005539B2 (en) * | 2008-10-31 | 2011-08-23 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8255057B2 (en) | 2009-01-29 | 2012-08-28 | Nevro Corporation | Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions |
| WO2010054116A1 (en) * | 2008-11-10 | 2010-05-14 | Cardiac Pacemakers, Inc. | Distal end converter for a medical device lead |
| US20150105840A1 (en) * | 2008-12-05 | 2015-04-16 | Spr Therapeutics, Llc | Systems and methods to place one or more leads in tissue for providing functional and/or therapeutic stimulation |
| WO2010088539A1 (en) | 2009-01-30 | 2010-08-05 | Medtronic, Inc. | Detecting and treating electromechanical dissociation of the heart |
| EP2421600B1 (en) | 2009-04-22 | 2014-03-05 | Nevro Corporation | Spinal cord modulation systems for inducing paresthetic and anesthetic effects |
| EP2586488B1 (en) | 2009-04-22 | 2017-03-15 | Nevro Corporation | Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems |
| US8954167B2 (en) * | 2009-05-26 | 2015-02-10 | Cardiac Pacemakers, Inc. | Helically formed coil for a neural cuff electrode |
| EP2453975B1 (en) * | 2009-07-15 | 2016-11-02 | Cardiac Pacemakers, Inc. | Remote sensing in an implantable medical device |
| EP2454697B1 (en) | 2009-07-15 | 2019-05-01 | Cardiac Pacemakers, Inc. | Remote pace detection in an implantable medical device |
| WO2011008749A2 (en) * | 2009-07-15 | 2011-01-20 | Cardiac Pacemakers, Inc. | Physiologicl vibration detection in an implanted medical device |
| AU2010315396B2 (en) | 2009-10-27 | 2016-05-05 | Nuvaira, Inc | Delivery devices with coolable energy emitting assemblies |
| US20120226091A1 (en) * | 2011-03-06 | 2012-09-06 | Mishelevich David J | Ultrasound neuromodulation treatment of pain |
| US9770204B2 (en) * | 2009-11-11 | 2017-09-26 | Medtronic, Inc. | Deep brain stimulation for sleep and movement disorders |
| JP6000851B2 (ja) | 2009-11-11 | 2016-10-05 | ホライラ， インコーポレイテッド | 組織治療および狭窄制御のためのシステム、装置、および方法 |
| US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
| US20130178765A1 (en) * | 2011-11-29 | 2013-07-11 | David J. Mishelevich | Ultrasound neuromodulation of spinal cord |
| AU2011239668B2 (en) * | 2010-04-15 | 2014-04-17 | Cardiac Pacemakers, Inc. | Autonomic modulation using transient response with intermittent neural stimulation |
| EP2575961B1 (en) | 2010-06-03 | 2018-08-29 | Cardiac Pacemakers, Inc. | System for spatially selective vagus nerve stimulation |
| AU2011261702B2 (en) | 2010-06-03 | 2014-11-27 | Cardiac Pacemakers, Inc. | System for controlling target of neurostimulation using temporal parameters |
| AU2011267992B2 (en) | 2010-06-18 | 2013-10-24 | Cardiac Pacemakers, Inc. | Neurostimulation system with control using evoked responses |
| US9211411B2 (en) | 2010-08-26 | 2015-12-15 | Medtronic, Inc. | Therapy for rapid eye movement behavior disorder (RBD) |
| EP3002037B1 (en) | 2010-09-15 | 2018-06-06 | Cardiac Pacemakers, Inc. | Automatic selection of lead configuration for a neural stimulation lead |
| US8788047B2 (en) | 2010-11-11 | 2014-07-22 | Spr Therapeutics, Llc | Systems and methods for the treatment of pain through neural fiber stimulation |
| US8788048B2 (en) | 2010-11-11 | 2014-07-22 | Spr Therapeutics, Llc | Systems and methods for the treatment of pain through neural fiber stimulation |
| US8788046B2 (en) | 2010-11-11 | 2014-07-22 | Spr Therapeutics, Llc | Systems and methods for the treatment of pain through neural fiber stimulation |
| US9393415B2 (en) * | 2010-12-29 | 2016-07-19 | Cardiac Pacemakers, Inc. | Systems and methods for using electrical impedance for neuro cardiac therapy |
| WO2012091849A1 (en) * | 2010-12-29 | 2012-07-05 | Cardiac Pacemakers, Inc. | Neuro cardiac therapy using sensed pressure |
| JP5797833B2 (ja) * | 2011-04-25 | 2015-10-21 | カーディアック ペースメイカーズ， インコーポレイテッド | 神経刺激中の頸部移動を考慮するシステム |
| US8876727B2 (en) | 2011-05-19 | 2014-11-04 | Medtronic, Inc. | Phrenic nerve stimulation detection using heart sounds |
| US8617082B2 (en) | 2011-05-19 | 2013-12-31 | Medtronic, Inc. | Heart sounds-based pacing optimization |
| US8777874B2 (en) * | 2011-05-24 | 2014-07-15 | Medtronic, Inc. | Acoustic based cough detection |
| US9026214B2 (en) | 2011-06-23 | 2015-05-05 | Cardiac Pacemakers, Inc. | Systems and methods for avoiding aspiration during autonomic modulation therapy |
| EP2726142B1 (en) | 2011-06-28 | 2017-05-10 | Cardiac Pacemakers, Inc. | Strain relief feature for an implantable medical device lead |
| AU2012279403B2 (en) | 2011-07-07 | 2015-05-28 | Cardiac Pacemakers, Inc. | Insulation and stability features for an implantable medical device lead |
| AU2012304370B2 (en) | 2011-09-08 | 2016-01-28 | Nevro Corporation | Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods |
| US8700150B2 (en) | 2012-01-17 | 2014-04-15 | Cyberonics, Inc. | Implantable neurostimulator for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration |
| US8886311B2 (en) | 2012-01-27 | 2014-11-11 | Medtronic, Inc. | Techniques for mitigating motion artifacts from implantable physiological sensors |
| JP2013165768A (ja) * | 2012-02-14 | 2013-08-29 | Olympus Corp | 神経刺激装置およびその制御方法 |
| JP6133393B2 (ja) | 2012-03-19 | 2017-05-24 | カーディアック ペースメイカーズ， インコーポレイテッド | 神経損傷をモニタするためのシステム及び方法 |
| JP6026567B2 (ja) | 2012-03-21 | 2016-11-16 | カーディアック ペースメイカーズ， インコーポレイテッド | 迷走神経を刺激するためのシステムおよび方法 |
| US9403007B2 (en) | 2012-06-14 | 2016-08-02 | Cardiac Pacemakers, Inc. | Systems and methods to reduce syncope risk during neural stimulation therapy |
| US8688212B2 (en) | 2012-07-20 | 2014-04-01 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing bradycardia through vagus nerve stimulation |
| WO2014055408A1 (en) | 2012-10-02 | 2014-04-10 | Cardiac Pacemakers, Inc. | Pinch to open cuff electrode |
| EP2903685B1 (en) | 2012-10-02 | 2019-08-07 | Cardiac Pacemakers, Inc. | Pinch to open cuff electrode |
| CN103785105B (zh) * | 2012-10-30 | 2016-08-17 | 苏州景昱医疗器械有限公司 | 一种病人控制器、植入式神经刺激系统及反馈调节方法 |
| US9643008B2 (en) | 2012-11-09 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing post-exercise recovery through vagus nerve stimulation |
| US9452290B2 (en) | 2012-11-09 | 2016-09-27 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation |
| US8923964B2 (en) | 2012-11-09 | 2014-12-30 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation |
| US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
| WO2014106023A1 (en) | 2012-12-28 | 2014-07-03 | Cardiac Pacemakers, Inc. | Stimulation cuff and implantation tool |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| EP3498332B1 (en) | 2013-01-21 | 2021-07-14 | Cala Health, Inc. | Devices for controlling tremor |
| US9295840B1 (en) | 2013-01-22 | 2016-03-29 | Nevro Corporation | Systems and methods for automatically programming patient therapy devices |
| US9731133B1 (en) | 2013-01-22 | 2017-08-15 | Nevro Corp. | Systems and methods for systematically testing a plurality of therapy programs in patient therapy devices |
| US9895538B1 (en) | 2013-01-22 | 2018-02-20 | Nevro Corp. | Systems and methods for deploying patient therapy devices |
| US9320889B2 (en) | 2013-02-13 | 2016-04-26 | Cardiac Pacemakers, Inc. | Cuff electrode with integrated tendril |
| US20140249378A1 (en) * | 2013-03-02 | 2014-09-04 | Isonea Limited | Systems, methods and kits for measuring cough and respiratory rate using an accelerometer |
| US9643011B2 (en) | 2013-03-14 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmic risk during sleep through vagus nerve stimulation |
| JP2016512758A (ja) | 2013-03-15 | 2016-05-09 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | 閾値以下の治療を患者に提供するシステム及び方法 |
| US9440076B2 (en) * | 2013-03-15 | 2016-09-13 | Globus Medical, Inc. | Spinal cord stimulator system |
| US9895539B1 (en) | 2013-06-10 | 2018-02-20 | Nevro Corp. | Methods and systems for disease treatment using electrical stimulation |
| ES2964217T3 (es) * | 2013-07-19 | 2024-04-04 | Med El Elektromedizinische Geraete Gmbh | Pulsos trifásicos para reducir los efectos secundarios no deseables en implantes cocleares |
| US9999773B2 (en) | 2013-10-30 | 2018-06-19 | Cyberonics, Inc. | Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters |
| CN105873504A (zh) * | 2013-11-01 | 2016-08-17 | 美敦力监控公司 | 充血性心力衰竭风险状态确定方法及相关设备 |
| US10149978B1 (en) | 2013-11-07 | 2018-12-11 | Nevro Corp. | Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods |
| US9511228B2 (en) | 2014-01-14 | 2016-12-06 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing hypertension through renal denervation and vagus nerve stimulation |
| US9415224B2 (en) | 2014-04-25 | 2016-08-16 | Cyberonics, Inc. | Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction |
| US9950169B2 (en) | 2014-04-25 | 2018-04-24 | Cyberonics, Inc. | Dynamic stimulation adjustment for identification of a neural fulcrum |
| US9272143B2 (en) | 2014-05-07 | 2016-03-01 | Cyberonics, Inc. | Responsive neurostimulation for the treatment of chronic cardiac dysfunction |
| US9409024B2 (en) | 2014-03-25 | 2016-08-09 | Cyberonics, Inc. | Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction |
| US9713719B2 (en) | 2014-04-17 | 2017-07-25 | Cyberonics, Inc. | Fine resolution identification of a neural fulcrum for the treatment of chronic cardiac dysfunction |
| AU2015271774B2 (en) | 2014-06-02 | 2020-04-16 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
| US9770599B2 (en) | 2014-08-12 | 2017-09-26 | Cyberonics, Inc. | Vagus nerve stimulation and subcutaneous defibrillation system |
| US9737716B2 (en) | 2014-08-12 | 2017-08-22 | Cyberonics, Inc. | Vagus nerve and carotid baroreceptor stimulation system |
| US9533153B2 (en) | 2014-08-12 | 2017-01-03 | Cyberonics, Inc. | Neurostimulation titration process |
| US9924904B2 (en) | 2014-09-02 | 2018-03-27 | Medtronic, Inc. | Power-efficient chopper amplifier |
| WO2016061045A1 (en) | 2014-10-13 | 2016-04-21 | Cardiac Pacemakers, Inc. | Systems and methods for delivering vagal therapy |
| CA2965780A1 (en) | 2014-11-03 | 2016-05-12 | Galvani Bioelectronics Limited | Neuromodulation device |
| US9504832B2 (en) | 2014-11-12 | 2016-11-29 | Cyberonics, Inc. | Neurostimulation titration process via adaptive parametric modification |
| US9895543B2 (en) * | 2014-12-22 | 2018-02-20 | Biotronik Se & Co. Kg | Implantable pulse generator system for vagal nerve stimulation |
| WO2016126718A1 (en) * | 2015-02-04 | 2016-08-11 | Boston Scientific Neuromodulation Corporation | Method and apparatus for programming charge recovery in neurostimulation waveform |
| US9517344B1 (en) | 2015-03-13 | 2016-12-13 | Nevro Corporation | Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator |
| US20180116541A1 (en) * | 2015-04-21 | 2018-05-03 | The Regents Of The University Of California | System and Method for Monitoring and Treating Arrhythmia and Cardiac Function via the Intrinsic Cardiac Nervous System |
| CN119565022A (zh) | 2015-06-10 | 2025-03-07 | 卡拉健康公司 | 用于外周神经刺激以利用可拆卸治疗和监测单元治疗震颤的系统和方法 |
| EP3113033B1 (fr) | 2015-06-29 | 2019-01-09 | Sorin CRM SAS | Système de traitement par stimulation, notamment du nerf vague, par mise en oeuvre d'un modèle de transition d'états |
| EP3111991B1 (fr) | 2015-06-29 | 2020-01-29 | Sorin CRM SAS | Système de traitement par stimulation, notamment de stimulation du nerf vague, par mise en oeuvre d'un modèle de transition d'états autoadaptable en fonction des niveaux physiques ou physiologiques |
| EP3111992B1 (fr) | 2015-06-29 | 2018-08-01 | Sorin CRM SAS | Système de traitement par stimulation, notamment de stimulation du nerf vague, par mise en oeuvre d'un modèle de transition d'état opérant à des résolutions temporelles ou spatiales multiples |
| EP3111990B1 (fr) | 2015-06-29 | 2019-02-27 | Sorin CRM SAS | Système de traitement par stimulation, notamment de stimulation du nerf vague, par mise en oeuvre d'un modèle de transition d'état avec apprentissage préalable |
| US20170007497A1 (en) * | 2015-07-08 | 2017-01-12 | James Madison Innovations, Inc. | Vibratory Cough Suppression |
| WO2017023864A1 (en) | 2015-07-31 | 2017-02-09 | Cala Health, Inc. | Systems, devices, and method for the treatment of osteoarthritis |
| AU2016308764B2 (en) * | 2015-08-18 | 2021-04-29 | University Of Louisville Research Foundation, Inc. | Sync pulse detector |
| US10675468B2 (en) * | 2015-09-18 | 2020-06-09 | Medtronic, Inc. | Electrical stimulation therapy for inducing patient sensations |
| US10300282B2 (en) | 2015-09-18 | 2019-05-28 | Medtronic, Inc. | Electrical stimulation therapy for inducing patient sensations |
| EP3352843B1 (en) | 2015-09-23 | 2021-06-23 | Cala Health, Inc. | Device for peripheral nerve stimulation in the finger to treat hand tremors |
| WO2017062379A1 (en) * | 2015-10-05 | 2017-04-13 | Cyberonics, Inc. | Stimulation suspension in response to patient discomfort or state |
| US10300277B1 (en) | 2015-12-14 | 2019-05-28 | Nevro Corp. | Variable amplitude signals for neurological therapy, and associated systems and methods |
| WO2017132067A2 (en) | 2016-01-21 | 2017-08-03 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| CN109069821A (zh) | 2016-02-29 | 2018-12-21 | 加尔瓦尼生物电子有限公司 | 神经调节设备 |
| CN109310863A (zh) * | 2016-03-09 | 2019-02-05 | 卡迪诺米克公司 | 心脏收缩性神经刺激系统和方法 |
| DE102016104913B4 (de) * | 2016-03-16 | 2018-04-26 | Forschungszentrum Jülich GmbH | Vorrichtung zur effektiven, invasiven und amplitudenmodulierten Neurostimulation |
| EP3429680A1 (fr) * | 2016-03-18 | 2019-01-23 | Sorin CRM SAS | Dispositif médical implantable actif de traitement combiné du rythme cardiaque et du rythme respiratoire |
| US10124170B2 (en) | 2016-06-13 | 2018-11-13 | Cyberonics, Inc. | Neurostimulator with titration assist |
| IL264116B2 (en) * | 2016-07-08 | 2024-01-01 | Cala Health Inc | Systems and methods for stimulating n nerves with exactly n electrodes and improved dry electrodes |
| WO2018039117A1 (en) | 2016-08-22 | 2018-03-01 | Boston Scientific Neuromodulation Corporation | Neuromodulation system for providing paresthesia and analgesia and a system with leads and with electrodes |
| CN109803717B (zh) | 2016-08-25 | 2024-01-09 | 卡拉健康公司 | 通过周围神经刺激治疗心脏机能障碍的系统和方法 |
| US11540973B2 (en) | 2016-10-21 | 2023-01-03 | Spr Therapeutics, Llc | Method and system of mechanical nerve stimulation for pain relief |
| CN106821357B (zh) * | 2016-11-18 | 2019-05-31 | 温州芳植生物科技有限公司 | 一种针对肌强直、肌痉挛病人的防摔装置 |
| CN106730335A (zh) * | 2016-12-20 | 2017-05-31 | 北京品驰医疗设备有限公司 | 一种骶神经电刺激疗法的参数输入方法及系统 |
| CN106512215B (zh) * | 2016-12-20 | 2023-05-05 | 北京品驰医疗设备有限公司 | 一种骶神经电刺激疗法的参数输入方法 |
| CN106621039A (zh) * | 2016-12-20 | 2017-05-10 | 北京品驰医疗设备有限公司 | 一种骶神经电刺激疗法的参数输入方法及系统 |
| CN106730334B (zh) * | 2016-12-20 | 2023-05-02 | 北京品驰医疗设备有限公司 | 一种骶神经电刺激系统 |
| EP3606604A4 (en) | 2017-04-03 | 2020-12-16 | Cala Health, Inc. | PERIPHERAL NEUROMODULATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH BLADDER HYPERACTIVITY |
| GB201709666D0 (en) * | 2017-06-16 | 2017-08-02 | Ucl Business Plc | Detecting activity in peripheral nerves |
| US12029591B2 (en) | 2017-06-20 | 2024-07-09 | Livanova Usa, Inc. | Titration assist management dashboard |
| JP7245233B2 (ja) * | 2017-09-14 | 2023-03-23 | リヴァノヴァ ユーエスエイ インコーポレイテッド | 植え込み型神経刺激装置のためのカスタマイズ可能な漸増 |
| US11857778B2 (en) | 2018-01-17 | 2024-01-02 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| EP3824556B1 (en) * | 2018-07-16 | 2024-02-14 | Mayo Foundation for Medical Education and Research | Systems and methods for low-power encoding of continuous physiological signals in a remote physiological monitor |
| US11590352B2 (en) | 2019-01-29 | 2023-02-28 | Nevro Corp. | Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| EP4347001B1 (en) | 2021-05-25 | 2026-03-25 | Nevro Corp. | Modified high frequency neuromodulation signals, and associated systems |
| US12484962B2 (en) | 2022-07-01 | 2025-12-02 | Artha Partners B.V. | Systems and methods of denervation around subclavian arteries |
| US12366583B2 (en) | 2022-10-24 | 2025-07-22 | West Virginia University Board of Governors on behalf of West Virginia University | Methods of improving neurodegenerative disorders by targeted delivery of therapeutic agents |
| CN115738077A (zh) * | 2022-11-04 | 2023-03-07 | 西安交通大学 | 一种迷走神经刺激上行传导阻滞装置及其控制方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040193231A1 (en) * | 2001-08-31 | 2004-09-30 | Biocontrol Medical Ltd. | Selective nerve fiber stimulation for treating heart conditions |
| US20060116737A1 (en) * | 2004-11-30 | 2006-06-01 | Cardiac Pacemakers, Inc. | Neural stimulation with avoidance of inappropriate stimulation |
| US20060190053A1 (en) * | 2002-03-22 | 2006-08-24 | Dobak John D Iii | Neural stimulation for treatment of metabolic syndrome and type 2 diabetes |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6141587A (en) * | 1996-08-19 | 2000-10-31 | Mower Family Chf Treatment Irrevocable Trust | Augmentation of muscle contractility by biphasic stimulation |
| US5205285A (en) * | 1991-06-14 | 1993-04-27 | Cyberonics, Inc. | Voice suppression of vagal stimulation |
| US5314454A (en) * | 1992-04-02 | 1994-05-24 | Jaeger Robert J | Method and apparatus of artifically stimulating cough reflex |
| US5330515A (en) * | 1992-06-17 | 1994-07-19 | Cyberonics, Inc. | Treatment of pain by vagal afferent stimulation |
| US6480743B1 (en) * | 2000-04-05 | 2002-11-12 | Neuropace, Inc. | System and method for adaptive brain stimulation |
| US6213960B1 (en) * | 1998-06-19 | 2001-04-10 | Revivant Corporation | Chest compression device with electro-stimulation |
| US6269270B1 (en) * | 1998-10-26 | 2001-07-31 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator |
| US7076307B2 (en) * | 2002-05-09 | 2006-07-11 | Boveja Birinder R | Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders |
| US6341236B1 (en) * | 1999-04-30 | 2002-01-22 | Ivan Osorio | Vagal nerve stimulation techniques for treatment of epileptic seizures |
| US7127290B2 (en) * | 1999-10-01 | 2006-10-24 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods predicting congestive heart failure status |
| US7623926B2 (en) * | 2000-09-27 | 2009-11-24 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
| US6775573B2 (en) * | 2001-03-01 | 2004-08-10 | Science Medicus Inc. | Electrical method to control autonomic nerve stimulation of gastrointestinal tract |
| US6684105B2 (en) * | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
| US7974693B2 (en) * | 2001-08-31 | 2011-07-05 | Bio Control Medical (B.C.M.) Ltd. | Techniques for applying, configuring, and coordinating nerve fiber stimulation |
| US7050856B2 (en) * | 2002-01-11 | 2006-05-23 | Medtronic, Inc. | Variation of neural-stimulation parameters |
| EP1426078A1 (en) * | 2002-12-04 | 2004-06-09 | Terumo Kabushiki Kaisha | Heart treatment equipment for preventing fatal arrhythmia |
| EP1601413B1 (en) * | 2003-02-21 | 2006-09-20 | Medtronic, Inc. | Implantable neurostimulator programming with battery longevity indication |
| JP4252830B2 (ja) * | 2003-03-24 | 2009-04-08 | テルモ株式会社 | 心臓治療装置 |
| US7894908B2 (en) * | 2003-04-02 | 2011-02-22 | Medtronic, Inc. | Neurostimulation therapy optimization based on a rated session log |
| US7548786B2 (en) * | 2003-04-02 | 2009-06-16 | Medtronic, Inc. | Library for management of neurostimulation therapy programs |
| US7489970B2 (en) * | 2003-04-02 | 2009-02-10 | Medtronic, Inc. | Management of neurostimulation therapy using parameter sets |
| US7463928B2 (en) * | 2003-04-25 | 2008-12-09 | Medtronic, Inc. | Identifying combinations of electrodes for neurostimulation therapy |
| AU2004261290A1 (en) * | 2003-08-01 | 2005-02-10 | Northstar Neuroscience, Inc. | Apparatus and methods for applying neural stimulation to a patient |
| US7787946B2 (en) * | 2003-08-18 | 2010-08-31 | Cardiac Pacemakers, Inc. | Patient monitoring, diagnosis, and/or therapy systems and methods |
| US7252090B2 (en) * | 2003-09-15 | 2007-08-07 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using neural network |
| US7617002B2 (en) | 2003-09-15 | 2009-11-10 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using decision trees |
| US8396565B2 (en) * | 2003-09-15 | 2013-03-12 | Medtronic, Inc. | Automatic therapy adjustments |
| US7184837B2 (en) * | 2003-09-15 | 2007-02-27 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using bayesian networks |
| US7239926B2 (en) * | 2003-09-15 | 2007-07-03 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using genetic algorithms |
| US20050070970A1 (en) * | 2003-09-29 | 2005-03-31 | Knudson Mark B. | Movement disorder stimulation with neural block |
| US7206632B2 (en) * | 2003-10-02 | 2007-04-17 | Medtronic, Inc. | Patient sensory response evaluation for neuromodulation efficacy rating |
| US8467876B2 (en) * | 2003-10-15 | 2013-06-18 | Rmx, Llc | Breathing disorder detection and therapy delivery device and method |
| EP1786510A4 (en) * | 2004-07-15 | 2009-12-02 | Northstar Neuroscience Inc | SYSTEMS AND METHOD FOR INCREASING OR INFLUENCING THE EFFICIENCY OR EFFECTIVENESS OF NEURAL STIMULATION |
| US7819909B2 (en) * | 2004-07-20 | 2010-10-26 | Medtronic, Inc. | Therapy programming guidance based on stored programming history |
| JP2008516696A (ja) * | 2004-10-18 | 2008-05-22 | ルイジアナ テック ユニバーシティ ファウンデーション | 神経障害の検出、予防および／または治療のための医療装置ならびにその医療装置に関連する方法 |
| US7366571B2 (en) * | 2004-12-10 | 2008-04-29 | Cyberonics, Inc. | Neurostimulator with activation based on changes in body temperature |
| US8600521B2 (en) | 2005-01-27 | 2013-12-03 | Cyberonics, Inc. | Implantable medical device having multiple electrode/sensor capability and stimulation based on sensed intrinsic activity |
| US7672728B2 (en) * | 2005-12-28 | 2010-03-02 | Cardiac Pacemakers, Inc. | Neural stimulator to treat sleep disordered breathing |
| US7912537B2 (en) * | 2006-04-27 | 2011-03-22 | Medtronic, Inc. | Telemetry-synchronized physiological monitoring and therapy delivery systems |
| AU2012200979B2 (en) | 2006-08-25 | 2013-08-29 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
| US8103341B2 (en) | 2006-08-25 | 2012-01-24 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
| US8600505B2 (en) | 2011-12-07 | 2013-12-03 | Cyberonics, Inc. | Implantable device for facilitating control of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
-
2006
- 2006-08-25 US US11/467,264 patent/US8103341B2/en not_active Expired - Fee Related
-
2007
- 2007-06-29 AU AU2007287006A patent/AU2007287006B2/en not_active Ceased
- 2007-06-29 WO PCT/US2007/072444 patent/WO2008024557A1/en not_active Ceased
- 2007-06-29 CN CN2007800315349A patent/CN101505827B/zh not_active Expired - Fee Related
- 2007-06-29 JP JP2009525669A patent/JP2010501269A/ja active Pending
- 2007-06-29 EP EP15155658.6A patent/EP2902076A1/en not_active Withdrawn
- 2007-06-29 CN CN201310009045.0A patent/CN103083810B/zh not_active Expired - Fee Related
- 2007-06-29 EP EP07799163.6A patent/EP2077893B1/en not_active Not-in-force
-
2012
- 2012-01-23 US US13/356,380 patent/US8527042B2/en active Active
-
2013
- 2013-08-28 US US14/012,036 patent/US8897881B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040193231A1 (en) * | 2001-08-31 | 2004-09-30 | Biocontrol Medical Ltd. | Selective nerve fiber stimulation for treating heart conditions |
| US20060190053A1 (en) * | 2002-03-22 | 2006-08-24 | Dobak John D Iii | Neural stimulation for treatment of metabolic syndrome and type 2 diabetes |
| US20060116737A1 (en) * | 2004-11-30 | 2006-06-01 | Cardiac Pacemakers, Inc. | Neural stimulation with avoidance of inappropriate stimulation |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8897881B2 (en) | 2006-08-25 | 2014-11-25 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2902076A1 (en) | 2015-08-05 |
| WO2008024557A1 (en) | 2008-02-28 |
| US8897881B2 (en) | 2014-11-25 |
| US20120123494A1 (en) | 2012-05-17 |
| JP2010501269A (ja) | 2010-01-21 |
| US8103341B2 (en) | 2012-01-24 |
| CN103083810A (zh) | 2013-05-08 |
| EP2077893B1 (en) | 2015-07-22 |
| CN103083810B (zh) | 2016-04-20 |
| CN101505827B (zh) | 2013-02-27 |
| EP2077893A1 (en) | 2009-07-15 |
| AU2007287006A1 (en) | 2008-02-28 |
| CN101505827A (zh) | 2009-08-12 |
| US8527042B2 (en) | 2013-09-03 |
| US20130345776A1 (en) | 2013-12-26 |
| US20080051839A1 (en) | 2008-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11446501B2 (en) | Systems and methods for delivering vagal nerve stimulation | |
| AU2007287006B2 (en) | System for abating neural stimulation side effects | |
| US8447394B2 (en) | Physical conditioning system, device and method | |
| US8630716B2 (en) | Systems and methods for providing neural stimulation transitions | |
| US8725247B2 (en) | Unidirectional neural stimulation systems, devices and methods | |
| AU2012200979B2 (en) | System for abating neural stimulation side effects | |
| AU2011250875A1 (en) | Unidirectional neural stimulation systems, devices and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |